News

Pulmonology Advisor2d
JAK Inhibitors Linked to Reduced Mortality in Patients Hospitalized With COVID-19
Janus kinase (JAK) inhibitors are associated with decreased mortality and fewer serious adverse events among adults hospitalized with COVID-19.
European Medical Journal4d
JAK Inhibition Protects Against Immunotherapy-Driven Diabetes
Discover a study uncovering how JAK inhibitors protect against autoimmune diabetes triggered by cancer immunotherapy.